SCHEMBL13544722

SCHEMBL13544722

CC(=O)c1cc(C(=O)NC2CC2)ccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 2/20 0.52
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
KDM4E B2RXH2 1/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
MAPK1 P28482 1/20 0.52
HPGD P15428 5/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MAPK14 Q16539 1/20 0.50
CNR2 P34972 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
TAS1R3 Q7RTX0 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
P2RX7 Q99572 1/20 0.48
ADRA2A P08913 1/20 0.47
HRH1 P35367 1/20 0.47
HTR2B P41595 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13544509 0.86 MEN1 (0.53) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL18835454 0.85 MEN1 (0.52) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL17149226 0.82 HPGD (0.51) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL14568525 0.81 MEN1 (0.54) KMT2AMEN1KDM4EPOLBMAPT
SCHEMBL2085543 0.80 KMT2A (0.56) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL29138050 0.79 KMT2A (0.52) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL18835452 0.79 HPGD (0.55) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL178563 0.78 MEN1 (0.68) KMT2AMEN1KDM4EPOLBMAPT
SCHEMBL5630057 0.78 KMT2A (0.54) SMYD3KMT2AMEN1KDM4EPOLB
SCHEMBL2946787 0.78 KMT2A (0.54) SMYD3KMT2AMEN1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed